Senores Pharmaceuticals Ltd (NSE:SENORES) Share Price

Company Profile

Business description
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
Contact
Ambali Bopal Road
1101 to 1103, 11th floor, South Tower, ONE 42
Opposite Jayantilal Park
AhmedabadGJ380054
IND
T: +91 7929999857
https://www.senorespharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2026
Employees
145

Recommended

a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.

Angus Hewitt, CFA | 19 August 2025

Cochlear’s met expectations, but investors overly optimistic.

Shane Ponraj, CFA | 18 August 2025

Margins improve but primary market is limited.

Shane Ponraj, CFA | 17 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,173.80	59.70	-0.65%
CAC 40	7,979.08	95.03	1.21%
DAX 40	24,423.07	108.30	0.45%
Dow JONES (US)	44,922.27	10.45	0.02%
FTSE 100	9,189.22	31.48	0.34%
HKSE	25,122.90	53.95	-0.21%
NASDAQ	21,314.95	314.82	-1.46%
Nikkei 225	43,546.29	168.02	-0.38%
NZX 50 Index	12,928.68	41.96	-0.32%
S&P 500	6,411.37	37.78	-0.59%
S&P/ASX 200	8,896.20	63.10	-0.70%
SSE Composite Index	3,727.29	0.74	-0.02%